"Kongshan Ci" has completed Series A financing

36Kr has learned that recently, Kongshanci, a company focusing on the new-generation brain-computer interaction neuroregulation technology, announced the completion of its Series A financing. This round is led by Oriental Fortune Capital, with participation from Yun Partners. Existing investors Dao Venture Capital and Yunqi Capital continue to increase their investment, while PeakView Capital acts as the exclusive financial advisor. The raised funds will be mainly used for product R&D and iteration, medical device registration application, and global expansion.